Arti Shukla

Jan 24, 2025 | downtoearth.org.in | Arti Shukla |Anurag Sharma |Meera Devi |Amit Vikram |Christopher Imler

Discover how natural farming in Solan, Himachal Pradesh, is transforming agriculture with sustainable practices that enhance soil health, reduce costs, and mitigate climate change. Learn about the success stories and initiatives driving this eco-friendly revolution.

Feb 21, 2024 | asbestos.com | Arti Shukla |Sean Marchese |Amy Edel

The U.S. Food and Drug Administration granted fast-track designation to a new therapeutic cancer vaccine. The approval is for UV1 in combination with the immunotherapy drugs Opdivo (nivolumab) and Yervoy (ipilimumab) to manage malignant pleural mesothelioma that can’t be managed with surgery. Therapeutic cancer vaccines, unlike preventive vaccines, treat existing cancers. Fast Track expedites the development of drug reviews for severe conditions.

Dec 19, 2023 | asbestos.com | Arti Shukla |Sean Marchese |Amy Edel

Multinational biopharmaceutical company Polaris Group announced their application for a rolling submission of a new mesothelioma treatment this month. The Biologic License Application for the experimental drug ADI-PEG 20 is the first step in U.S. Food and Drug Administration approval. The application outlines the use of ADI-PEG 20 for non-epithelioid mesothelioma alongside treatment with pemetrexed and platinum chemotherapy.